Skip to content
Drug recall · FDA · Published December 5, 2018

Pharmedium Services, LLC recalls Fentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%, Injection, 100 mL

PharMEDium Services recalls specific fentanyl and ropivacaine injections due to sub-potent risk. Learn product details and safety steps.

🇺🇸 FDA recall #D-0334-2019DrugPharMEDium ›
Take action

Contact the company & request your remedy

Recalling firmPharmedium Services, LLC150 N Field Dr Ste 350 · Lake Forest, IL 60045-2506
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

PharMEDium Services recalled certain fentanyl and ropivacaine injections because they may be less potent than intended. This could lead to ineffective pain management during medical procedures. Read more at govinfonow.com/recall/39383-pharmedium-fentanyl-ropivacaine-injections-recall-sub-potent-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39383-pharmedium-fentanyl-ropivacaine-injections-recall-sub-potent-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0334-2019

Cite this page

“PharMEDium Fentanyl Ropivacaine Injections Recall: Sub-potent Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39383-pharmedium-fentanyl-ropivacaine-injections-recall-sub-potent-risk. Based on FDA recall #D-0334-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0334-2019%22&limit=1).

Why it’s dangerous

Sub-potent means the medication may not work as intended at the prescribed dose. This could result in inadequate pain relief during medical procedures.

Who’s affected

Healthcare providers who use these injections for medical procedures may be affected. Patients receiving these injections under medical supervision are at low risk.

How to tell if you have this one

Check for the NDC code 61553-148-48 and expiration date 02/17/2019 on the 150 mL Intravia Bag packaging.

  • Brand
    PharMEDium
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide in the USA.
Recall numberProduct, codes & lotsQuantity
D-0333-2019Fentanyl Citrate 2 mcg per mL (100 mcg per 50 mL) and Ropivacaine HCl 0.1% in Sodium Chloride 0.9%, Injection, 50 mL total volume in a 60 mL BD Syringe, Rx Only, PharMEDium Services, LLC. 913 N. Davis Ave. Cleveland, MS 38732 NDC 61553-644-75.; Lot: 183220013C Exp. 12/19/2018295 50 ml in 60 ml syringes
D-0334-2019Fentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%, Injection, 100 mL total volume in a 150 mL Intravia Bag, Rx Only,PharMEDium Services, LLC. 913 N. Davis Ave. Cleveland, MS 38732. NDC 61553-148-48; Lot: 183230004C Exp. 02/17/2019295 100 mL in 150 mL Intravia bags
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC code 61553-148-48 and expiration date 02/17/2019 on the 150 mL Intravia Bag packaging.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to sub-potent risk, meaning it may not work as intended. Healthcare providers should not use these specific injections.

How can I tell if I have the recalled product?

Check for the NDC code 61553-148-48 and expiration date 02/17/2019 on the 150 mL Intravia Bag packaging.

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact PharMEDium Services for guidance.

Take action

Contact PharMEDium

We’ve drafted a message you can send PharMEDium to request your refund or repair — edit it as you like.

Subject: Recall D-0334-2019 — PharMEDium PharMEDium

Hello,

I own a PharMEDium that is covered by recall D-0334-2019 from PharMEDium.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0334-2019 (December 5, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0334-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA